Evaluation of Hypertriglyceridemia as a Mediator Between Endocrine Diseases and Pancreatitis in Dogs

J Am Anim Hosp Assoc. 2019 Mar/Apr;55(2):92-100. doi: 10.5326/JAAHA-MS-6791. Epub 2019 Jan 17.

Abstract

The role of hypertriglyceridemia (HTG) secondary to endocrine diseases in the occurrence of pancreatitis in dogs has not been fully investigated. The objective of the present study was to evaluate HTG as a mediator between endocrine diseases and pancreatitis in dogs. The study design was a retrospective case-control study. Medical records of dogs newly diagnosed with acutely presenting pancreatitis between 2012 and 2014 were reviewed for the presence or absence of hyperadrenocorticism (HAC), diabetes mellitus (DM), and hypothyroidism. A matched case-control analysis was performed, and the association between endocrine diseases and pancreatitis was evaluated using multiple logistic regression analysis. In dogs with pancreatitis, the odds of HAC (P < .001) and DM (P < .001) were 4.5 and 12.4 times that of dogs without pancreatitis, respectively. HTG significantly mediated the association between DM and pancreatitis but not between HAC and pancreatitis. Additional studies will be necessary to confirm these findings and to further elucidate the associations between endocrine diseases and pancreatitis.

MeSH terms

  • Adrenocortical Hyperfunction / complications
  • Adrenocortical Hyperfunction / veterinary*
  • Animals
  • Case-Control Studies
  • Diabetes Mellitus / etiology
  • Diabetes Mellitus / veterinary*
  • Dog Diseases / etiology*
  • Dogs
  • Female
  • Hypertriglyceridemia / complications
  • Hypertriglyceridemia / veterinary*
  • Hypothyroidism / complications
  • Hypothyroidism / veterinary*
  • Male
  • Pancreatitis / complications
  • Pancreatitis / veterinary*
  • Retrospective Studies